AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus
Patients suffering from congenital nephrogenic diabetes insipidus (NDI) fail to concentrate urine due to mutations in vasopressin type 2 receptor (V2R). Here Ando et al. show that agents disrupting the interaction between PKA and AKAPs restore aquaporin-2 activity downstream of V2R, offering a thera...
Enregistré dans:
Auteurs principaux: | Fumiaki Ando, Shuichi Mori, Naofumi Yui, Tetsuji Morimoto, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Sei Sasaki, Yoshiaki Kondo, Hiroyuki Kagechika, Shinichi Uchida |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8c60b14a92e94b27bd57f69fed3d984d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway
par: Fumiaki Ando, et autres
Publié: (2016) -
Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus
par: Lixia Wang, et autres
Publié: (2021) -
Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1.
par: Ronald A Merrill, et autres
Publié: (2011) -
Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
par: Takafumi Suzuki, et autres
Publié: (2017) -
Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice
par: Maria L. Thomsen, et autres
Publié: (2021)